Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q2 2021 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's size, with disproportionate scale relative to its smallness. Look for statements about current activity, demand, commitments arriving at scale large relative to company size. In the transcript, management discusses strong results, growth, but also mentions things like: "we are the only company in our space that has made 100% commitment to the channel" etc. But more importantly, they talk about pipeline, large deals, but is there a sense of disproportion? They mention "we have more six figure deals in our pipeline now than perhaps at any time during our history" - that's about pipeline, not necessarily current commitments. They also mention "we're seeing momentum with larger deals" and "large deals grew 30% year-over-year" - that's growth, but not necessarily disproportion relative to company size. They also mention "we are adding quota carrying sales reps" and "we plan to continue to add quota capacity" - that's investment. The question asks: does management convey that the business is small and what is happening now is disproportionately large? For example, a single customer or contract could rival a meaningful share of today's company. They mention "a seven figure win" and "over a dozen six figure deals" but that's not necessarily disproportionate to a company with revenue of ~$500M annualized. They also mention "we had 67 net new six figure customers" - that's a lot but not disproportionate. They also talk about "Tenable.ep" driving higher deal sizes, but again, that's growth. Look for explicit contrast: "how little the company has captured so far with the scale of what is already reaching it." They mention "we believe that attacks like those against Microsoft and Colonial Pipeline continue to elevate discussions about risk" but that's market. They also mention "we're seeing very strong early traction of our solution and an excited pace of pipeline creation" for Tenable.ad, but that's early. The key is whether management explicitly states that the current business is large relative to the company's size. They don't seem to say "we are small and this is huge" - they talk about growth and momentum, but not a disproportion. They do mention "we are the only company in our space that has made 100% commitment to the channel" - that's a strategic point.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.